SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1074248409350136v1
14/4/314    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Augusti, P. R.
Right arrow Articles by Emanuelli, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Augusti, P. R.
Right arrow Articles by Emanuelli, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Astaxanthin Reduces Oxidative Stress, but not Aortic Damage in Atherosclerotic Rabbits

Paula R. Augusti, MSc

Graduate Program in Biological Sciences/Biochemistry, Department of Biochemistry, Institute of Health Basic Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Greicy M. M. Conterato, MSc

Graduate Program in Toxicological Biochemistry, Center of Natural and Exact Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Sabrina Somacal, BSc

Integrated Center for Laboratory Analysis Development (NIDAL), Department of Alimentary Technology and Science, Center of Rural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Rocheli Sobieski, BSc

Integrated Center for Laboratory Analysis Development (NIDAL), Department of Alimentary Technology and Science, Center of Rural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Andréia Quatrin

Integrated Center for Laboratory Analysis Development (NIDAL), Department of Alimentary Technology and Science, Center of Rural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Luana Maurer

Integrated Center for Laboratory Analysis Development (NIDAL), Department of Alimentary Technology and Science, Center of Rural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Marta P. Rocha, MD

Department of Pathology, Center of Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Ione T. Denardin, MSc

Polytechnical School, Center of Rural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

Tatiana Emanuelli, PhD

Department of Food Technology and Science, Federal University of Santa Maria, Santa Maria, RS, Brazil, tatiemanuelli{at}smail.ufsm.br

We evaluated whether carotenoid astaxanthin (ASX) could prevent oxidative and atherosclerotic damage in rabbits. Rabbits received regular chow (control) or an atherogenic diet (1% cholesterol) alone or supplemented with 50, 100, and 500 mg% ASX for 60 days (n = 5-9 per group). The atherogenic diet increased the serum cholesterol levels and the ratio of the intima/media area in the aortic arch. These changes were not prevented by ASX. Atherosclerotic rabbits showed increased aortic lipid peroxidation and nonprotein thiol group (NPSH) levels along with inhibition of glutathione peroxidase (GSH-Px). All ASX doses attenuated lipid peroxidation and the increase in NPSH but not the inhibition of GSH-Px. Aortic superoxide dismutase (SOD), catalase (CAT), and thioredoxin reductase (TrxR) activities were enhanced in atherosclerotic rabbits. Although all ASX doses prevented the increase in SOD activity, only 100 and 500 mg% ASX prevented the increase in CAT activity. Furthermore, these same doses partially prevented the increase in TrxR activity, while 50 mg% ASX completely prevented the effects of the atherogenic diet on this enzyme. However, ASX did not attenuate the hypercholesterolemia or the atherosclerotic lesions caused by the atherogenic diet at any of the doses evaluated. Our results indicate that although ASX did not prevent hypercholesterolemia or atherosclerotic lesions, it could play a beneficial role by preventing lipid peroxidation and changes in antioxidant enzyme activities.

Key Words: antioxidant enzymes • carotenoids • intima • media ratio • thiobarbituric acid reactive substances

This version was published on December 1, 2009

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 14, No. 4, 314-322 (2009)
DOI: 10.1177/1074248409350136


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement